Tim Flaadt

7PUBLICATIONS
40CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

|Jan 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

Tim Flaadt, Jonas Rehm, Thorsten Simon

|Dec 26, 2023
NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP).

Tim Flaadt, Hannah Wild, Michael Abele

|Dec 09, 2023
Local MRI before and after Tumor Resection in Neuroblastoma: Impact of Residual Disease on Event Free Survival.

Jürgen F Schäfer, Sebastian Gassenmaier, Steven Warmann

|Oct 14, 2023
Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse.

Tim Flaadt, Martin Ebinger, Malin Schreiber

|Sep 28, 2023
Combined Metabolic and Functional Tumor Volumes on [18F]FDG-PET/MRI in Neuroblastoma Using Voxel-Wise Analysis.

Maryanna Chaika, Simon Männlin, Sebastian Gassenmaier

Pageof 2

Frequent Collaborators

4 joint publications

Peter Lang

4 joint publications

Jürgen Schäfer

4 joint publications

Thorsten Simon

3 joint publications

Holger N Lode